VIPoma Treatments

Find VIPoma Treatments

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in VIPoma.

Found 1 Approved Drug for VIPoma

Octreotide Acetate

Brand Names

Sandostatin, Octreotide, Bynfezia

Octreotide Acetate

Brand Names

Sandostatin, Octreotide, Bynfezia

Form: Injection, Kit

Method of administration: Subcutaneous, Intravenous, Intramuscular

FDA approval date: October 21, 1988

Classification: Somatostatin Analog

Sandostatin Injection is a somatostatin analogue indicated: Acromegaly : To reduce blood levels of growth hormone (GH) and insulin growth factor-1 (IGF-1; somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses.

Showing 1-1 of 1

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances